Tibulizumab is a tetravalent bispecific monoclonal antibody that acts as an antagonist against B-cell activating factor (BAFF) and IL-17A, with Kd values of 60 pM and 14 pM, respectively, and is suitable for research into autoimmune diseases.
CAS Number:
[1849636-24-3]
Target:
Interleukin|||TNF
* VAT and and shipping costs not included. Errors and price changes excepted